Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
74.19 USD | -0.93% | +3.73% | -6.78% |
30/04 | North American Morning Briefing : More Earnings -2- | DJ |
29/04 | Axsome Therapeutics Phase 3 Alzheimer's Treatment Trial is High Risk, High Reward, Morgan Stanley Says | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.78% | 3.52B | |
-3.79% | 87.06B | |
+2.76% | 40.25B | |
-17.49% | 31.09B | |
+54.94% | 24.74B | |
-13.13% | 15.91B | |
-9.12% | 11.96B | |
-15.45% | 11.92B | |
-42.56% | 11.61B | |
+5.24% | 8.73B |
- Stock Market
- Equities
- AXSM Stock
- News Axsome Therapeutics, Inc.
- Axsome Therapeutics : Reports Positive Results from Late-Stage Trial of Migraine Treatment